A Pilot study of adjuvant hepatic arterial infusion chemotherapy, associating 5-fluorouracil and leucovorin, after resection of colorectal cancer liver metastases
โ Scribed by H. Porte; H. De Moulins; L. Gambiez; A. Wurtz; P. Quandalle
- Book ID
- 114315256
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 482 KB
- Volume
- 4
- Category
- Article
- ISSN
- 0960-7404
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## BACKGROUND. Pharmacokinetic modulating chemotherapy (PMC) is a new therapeutic concept in combination with continuous 5-fluorouracil (5-FU) infusion and UFT. UFT enhanced plasma 5-FU concentration and antitumor effects during 5-FU infusion. The authors report on their experiences with arterial
## BACKGROUND. Greater than 50% of patients who undergo curative resection of liver metastases from colorectal carcinoma develop recurrent disease in the residual liver. Although several studies have attempted to use hepatic arterial infusion (HAI) chemotherapy to prevent recurrence, to the authors